Description
Unlock the full potential of your immune research with our Interferon 9-Plex Panel, designed to analyze key interferon biomarkers and provide an unparalleled look at the interferon response —Type I, Type II, and Type III—to provide comprehensive insights into antiviral responses, immune modulation, and the intricate mechanisms behind viral infections and autoimmune diseases.
Interferons (IFNs) were first identified over 50 years ago for their remarkable ability to confer viral resistance to cells. However, their role extends far beyond just antiviral activity. Today, we recognize IFNs as crucial players in both innate and adaptive immune responses, vital for tumor surveillance and defense, as well as for modulating immune cell function.
By analyzing these biomarkers simultaneously, you gain invaluable insights into the diverse roles of interferons in immune responses, making this panel an indispensable tool for exploring immunological and inflammatory conditions.
Indications:
Use this test to identify relevant therapy targets, determine disease mechanisms, and diagnose or monitor the following conditions:
- Viral Infections: Useful for detecting acute and chronic viral infections such as hepatitis B, hepatitis C, HIV, and respiratory viral infections including influenza and COVID-19.
- Autoimmune Diseases: Helps in diagnosing and managing autoimmune conditions like systemic lupus erythematosus (SLE), multiple sclerosis (MS), rheumatoid arthritis, and type 1 diabetes.
- Chronic Inflammatory Diseases: Assists in identifying chronic inflammatory conditions such as Crohn’s disease, psoriasis, and chronic obstructive pulmonary disease (COPD).
- Cancer Immunotherapy Monitoring: Monitors therapeutic response in cancer treatments, particularly for melanoma and renal cell carcinoma.
- Severe or Chronic Inflammation: Useful in conditions such as prolonged or periodic fever, severe or chronic inflammation, organ dysfunction, and investigation of cytokine storms seen in hemophagocytic lymphohistiocytosis (HLH) and related conditions.
Key Features:
- Comprehensive Biomarker Coverage: Provides a detailed analysis of 9 key biomarkers, ensuring a thorough diagnostic approach.
- CLIA Certified for Clinical Use: As a CLIA certified laboratory, we provide a panel that meets the highest standards of accuracy and reliability for clinical diagnostics.
- Versatility: Use this test to assess the interferon response in viral infections and autoimmune diseases.
- Sample flexibility: Reference intervals are available for PLASMA-EDTA and SERUM samples.
- Affordable Assay Services: We offer some of the most affordable assay services available, making advanced diagnostics accessible for clinical applications.
- Swift and Reliable Turnaround Time: We pride ourselves on a rapid turnaround time, with results typically delivered within 5 business days of receiving your specimen and payment.
Certified Excellence in Diagnostic Testing
Eve Technologies is certified by the Centers for Medicare & Medicaid Services (CMS) as a High Complexity International Laboratory under the Clinical Laboratory Improvement Amendments (CLIA), specializing in Diagnostic Immunology with a subspecialty in General Immunology (CLIA# 99D2283230). Additionally, we hold a clinical and public health laboratory license with the California Department of Public Health (COS-90013367). Our certification underscores our commitment to rigorous standards.
Clinicians: Please check with your State Agency to determine if additional licensure or registration requirements may apply.
! The interpretation of these test results should be correlated with clinical findings and other diagnostic tests. Biomarker levels can vary due to many biological, physiological, and diurnal factors; their clinical significance must be assessed by a qualified healthcare professional. This information is not intended to be used as the sole basis for diagnosis or treatment decisions. ​